Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

Completed · Phase 2

Conditions studied: Meibomian Gland Dysfunction

In brief

The objective of this study is to assess the safety and efficacy of testosterone 0.03% ophthalmic solution compared to vehicle for the treatment of meibomian gland dysfunction.

Key facts

Study ID

NCT00755183

Run by

ORA, Inc.

People needed

60

Starts

2008-07-01

Expected to finish

2009-04-01

Last updated by the study team

2020-10-22

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ophthalmic Research Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.